Sep 14, 2025

Collective Deliberation for Safer CBRN Decisions: A Multi-Agent LLM Debate Pipeline

Alexander Müller, Arsenijs Golicins, and Galina Lesnic

Large Language Models (LLMs) are increasingly deployed in high-stakes decision-making, including scenarios involving Chemical, Biological, Radiological, and Nuclear (CBRN) risks. However, hallucinations and inconsistencies make reliance on single models hazardous. Inspired by the “wisdom of crowds,” we test whether structured multi-agent debate can improve reliability without model retraining or architectural changes. Using five LLMs, we evaluate performance on LabSafetyBench, a 632-question laboratory safety dataset. Each agent independently answers, critiques peers, and updates responses over multiple rounds before consensus or majority vote. Across five runs, collective debate significantly outperformed the best individual model (median accuracy gain of 3.8 percentage points, p = .042). We also measure model persuasiveness when in the minority, finding large disparities across models. Stress-testing the method with an “impostor” agent—forced to argue for incorrect answers—reduced accuracy by only 7 percentage points, indicating resilience to adversarial persuasion. These results suggest that multi-LLM debate offers a practical safety wrapper for CBRN decision support, with potential to generalize to other high-risk domains. To facilitate reproducibility, we make our code available at https://github.com/AlexanderAKM/CBRN_ LLM_DEBATE

Reviewer's Comments

Reviewer's Comments

Arrow
Arrow
Arrow

This project makes a strong case that multi-agent debate can serve as a lightweight “safety wrapper” for LLMs in high-stakes contexts. The experiments are carefully designed and well executed. While LLM debate has existed for some time, the authors make a useful contribution by applying it in a CBRN-relevant setting and adding the impostor test, which provides valuable insight into robustness against adversarial persuasion.

For future work, it would be valuable to test the approach on other benchmarks such as WMDP, as well as on open-ended or scenario-based tasks that better reflect real-world CBRN decisions. Exploring alternative consensus mechanisms beyond majority voting could also be interesting.

This is very well structured, executed, and documented research. Impressed that you have such a clean paper and codebase after only a weekend sprint.

My main critique is it's unclear how this will realistically address CBRN risks. It seems to not address misuse, but rather is aimed at people doing legitimate life sciences research who may cause harm from using LLMs that are making errors/hallucinating? That doesn't seem like a high priority threat model on its face. I'd have liked to see some realistic personas or use cases that have caused this type of harm, or plausible future scenarios that you're addressing.

My other critique is on novelty. There are many papers on how debate improves the honesty/reliability of LLMs, and your paper does interesting work that generalizes those results to the lab safety context. However, no one really uses debate systems in practice because they're slow and cumbersome. Perhaps in high risk domains that tradeoff would be worth it, but I didn't see any discussion about whether your target audience would entertain that tradeoff (or any other adoption challenges that would stand in the way).

Smaller feedback on the writing: it was hard to understand the headline result after reading the abstract. I recommend dumbing it down more so people who are skimming will remember the key result (maybe bold it too). For your figure captions, don't just label what is being shown but also summarize the takeaway from the plots.

Key Strengths

The project was very well executed, with a clear and rigorous design. The introduction of the imposter training/agent was especially impressive, as it effectively tested and strengthened adversarial robustness across models.

The approach contributes meaningfully to the broader space, even without requiring domain-specific content.

The idea akin to cybersecurity took on the need for models to withstand adversarial manipulation.This could be useful if an unfriendly state were to "poison" decision support systems.

Specific Area of Improvement

The practical applications to CBRN decision-making were not convincingly connected. The project’s relevance to CBRN contexts felt somewhat abstract rather than grounded. This can be easily rectified, however, by explaining how this decision support system could work. I am also not entirely convinced that this advances the cause of mitigating CBRN risks. To cover this, maybe there could have been more elaboration on "Errors from hallucinations or inconsistencies can pose serious hazards, raising the question of how to improve LLM reliability."

The runtime of the model runs was not mentioned; if they take significant time, this could limit real-world usability.

How to Develop into Stronger Project/ Next Steps

Provide runtime benchmarks and efficiency considerations.

Strengthen the narrative connection to practical CBRN scenarios, and make the story about reducing risks clear.

Cite this work

@misc {

title={

(HckPrj) Collective Deliberation for Safer CBRN Decisions: A Multi-Agent LLM Debate Pipeline

},

author={

Alexander Müller, Arsenijs Golicins, and Galina Lesnic

},

date={

9/14/25

},

organization={Apart Research},

note={Research submission to the research sprint hosted by Apart.},

howpublished={https://apartresearch.com}

}

Recent Projects

Apr 27, 2026

OliGraph: graph-based screening of large oligopools

Existing synthesis screening tools cannot evaluate short oligonucleotide pools, whose overlapping fragments can be reassembled into regulated sequences via polymerase cycling assembly (PCA) yet fall below gene-length detection thresholds. We present OliGraph, an open-source tool that constructs a bi-directed overlap graph from an oligonucleotide pool and extracts contigs for downstream gene-length screening. An optional PCA mode retains only cross-strand overlaps consistent with PCA chemistry. We validated OliGraph in a blinded study across ten simulated pools (70–9,184 oligonucleotides, 30–300 bp) spanning four risk categories. BLAST screening of individual oligonucleotides failed to identify sequences of concern in most pools: three returned zero hits, and vector noise obscured true positives in the remainder. After OliGraph assembly, contig-level BLAST matched the longest assembled sequences (up to 1,905 bp) to sequences of concern at 97–100% identity. In one pool, assembly collapsed 1,634 individual BLAST results into 10 hits from a single contig, all assigned to the same source organism. PCA mode correctly distinguished assemblable from non-assemblable fragments within the same pool. Two pools with no assemblable structure yielded no contigs. OliGraph processed all pools in under 0.2 seconds, fast enough for real-time order screening and consistent with proposals to bring oligonucleotide orders within the scope of synthesis screening regulation.

Read More

Apr 27, 2026

BioRT-Bench: A Multi-Attack Red-Teaming Benchmark for Bio-Misuse Safeguards in Frontier LLMs

Frontier AI laboratories are expected to maintain safeguards against biological misuse, but whether deployed models actually refuse bio-misuse queries under adversarial pressure is largely unmeasured in the public literature. We introduce BioRT-Bench, a benchmark that runs four attack methods (direct request, PAIR, Crescendo, and base64 encoding) against four frontier models (Claude Sonnet 4.6, GPT-5.4, DeepSeek V4-flash, Kimi K2.5) across 40 prompts spanning five biosecurity-relevant categories. Responses are scored by a calibrated judge extending StrongREJECT with two bio-specific dimensions: specificity and actionability. We measure Attack Success Rate (ASR), where 0 means the model fully refused and 1 means it provided specific, actionable bio-misuse content. Our results reveal a sharp robustness divide: Chinese frontier models (DeepSeek, Kimi) have under 5% refusal rates even under direct request (ASR 0.88 and 0.79), while Western models (Claude, GPT) maintain substantially stronger safeguards (ASR 0.15 and 0.16). Crescendo is the most effective attack across all models, both in bypassing refusal and in eliciting actionable content. Claude Sonnet 4.6 is the most robust model tested, achieving 100% refusal against base64-encoded prompts.

Read More

Apr 27, 2026

PROTEUS (PROTein Evaluation for Unusual Sequences): Structure-Informed Safety Screening for de novo and Evasion-Prone Protein-Coding Sequences

AI protein design tools like RFdiffusion, ProteinMPNN, and Bindcraft make it trivial to produce low-homology sequences that fold into active, potentially hazardous architectures. However, sequence homology-based biosafety screening tools cannot detect proteins that pose functional risk through structurally novel mechanisms with no sequence precedent. We present a tiered computational pipeline that addresses this gap by combining MMseqs2 sequence alignment with structure-based comparison via FoldSeek and DALI against curated toxin databases totaling ~34,000 entries. AlphaFold2-predicted structures are screened for both global fold similarity (FoldSeek) and local active/allosteric site geometry (DALI), capturing convergent functional hazards that sequence screening misses. The pipeline was validated against a panel of toxins, benign proteins, structural mimics, and de novo-designed Munc13 binders, as well as modified ricin variants with residue substitutions. We additionally tested robustness to partial-synthesis evasion, where a bad actor submits multiple shorter coding sequences intended for downstream reassembly into a full toxin-coding gene. We found that while sequence-based screening did not identify any de novo ricin analogues with high certainty, the combined pipeline with FoldSeek and DALI identified all 24 tested de novo ricins as toxic.

Read More

Apr 27, 2026

OliGraph: graph-based screening of large oligopools

Existing synthesis screening tools cannot evaluate short oligonucleotide pools, whose overlapping fragments can be reassembled into regulated sequences via polymerase cycling assembly (PCA) yet fall below gene-length detection thresholds. We present OliGraph, an open-source tool that constructs a bi-directed overlap graph from an oligonucleotide pool and extracts contigs for downstream gene-length screening. An optional PCA mode retains only cross-strand overlaps consistent with PCA chemistry. We validated OliGraph in a blinded study across ten simulated pools (70–9,184 oligonucleotides, 30–300 bp) spanning four risk categories. BLAST screening of individual oligonucleotides failed to identify sequences of concern in most pools: three returned zero hits, and vector noise obscured true positives in the remainder. After OliGraph assembly, contig-level BLAST matched the longest assembled sequences (up to 1,905 bp) to sequences of concern at 97–100% identity. In one pool, assembly collapsed 1,634 individual BLAST results into 10 hits from a single contig, all assigned to the same source organism. PCA mode correctly distinguished assemblable from non-assemblable fragments within the same pool. Two pools with no assemblable structure yielded no contigs. OliGraph processed all pools in under 0.2 seconds, fast enough for real-time order screening and consistent with proposals to bring oligonucleotide orders within the scope of synthesis screening regulation.

Read More

Apr 27, 2026

BioRT-Bench: A Multi-Attack Red-Teaming Benchmark for Bio-Misuse Safeguards in Frontier LLMs

Frontier AI laboratories are expected to maintain safeguards against biological misuse, but whether deployed models actually refuse bio-misuse queries under adversarial pressure is largely unmeasured in the public literature. We introduce BioRT-Bench, a benchmark that runs four attack methods (direct request, PAIR, Crescendo, and base64 encoding) against four frontier models (Claude Sonnet 4.6, GPT-5.4, DeepSeek V4-flash, Kimi K2.5) across 40 prompts spanning five biosecurity-relevant categories. Responses are scored by a calibrated judge extending StrongREJECT with two bio-specific dimensions: specificity and actionability. We measure Attack Success Rate (ASR), where 0 means the model fully refused and 1 means it provided specific, actionable bio-misuse content. Our results reveal a sharp robustness divide: Chinese frontier models (DeepSeek, Kimi) have under 5% refusal rates even under direct request (ASR 0.88 and 0.79), while Western models (Claude, GPT) maintain substantially stronger safeguards (ASR 0.15 and 0.16). Crescendo is the most effective attack across all models, both in bypassing refusal and in eliciting actionable content. Claude Sonnet 4.6 is the most robust model tested, achieving 100% refusal against base64-encoded prompts.

Read More

This work was done during one weekend by research workshop participants and does not represent the work of Apart Research.
This work was done during one weekend by research workshop participants and does not represent the work of Apart Research.